RIGEL PHARMACEUTICALS INC (RIGL) has 36 open-market insider trades by 17 insiders since 2007. The most active filer is Ryan D. Maynard, CFO & VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Deerfield Partners, L.P. via James E. Flynn | 10% | — | 1 | $5.2M | 2011-05-26 |
| Ryan D. Maynard | CFOVP | — | 5 | $1.5M | 2017-11-03 |
| Raul R. Rodriguez | CEOPres | — | 5 | $1.4M | 2026-09-01 |
| BVF Inc/il | 10% | — | 1 | $1.3M | 2013-11-19 |
| Eldon C. Mayer III | CCOVP | — | 2 | $608K | 2018-09-11 |
| Anne-Marie Duliege | VP | — | 2 | $593K | 2018-09-17 |
| Donald G. Payan | EVPPres. Discovery&Research | — | 4 | $352K | 2016-08-30 |
| Dean L. Schorno | CFOVP | — | 4 | $310K | 2026-09-02 |
| Walter H. Moos | Dir | — | 1 | $145K | 2026-05-15 |
| Mark N. Lampert | 10% | — | 1 | $113K | 2013-06-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Kamil Ali-Jackson | Director | Sell | $88K | 2026-06-22 |
| Kamil Ali-Jackson | Director | Sell | $73K | 2026-05-26 |
| Walter H. Moos | Director | Sell | $145K | 2026-02-20 |
| Raymond J. Furey | EVP & GC +1 | Sell | $60K | 2025-02-04 |
| David A. Santos | EVP & Chief Commercial Officer | Sell | $84K | 2025-02-04 |
| Dean L. Schorno | CFO | Sell | $81K |
Companies that share insiders with RIGL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-02-04 |
| Raul R. Rodriguez | CEO & President | Sell | $304K | 2025-02-04 |
| Dean L. Schorno | CFO | Sell | $14K | 2024-02-02 |
| Raul R. Rodriguez | CEO & President | Sell | $60K | 2024-02-02 |
| David A. Santos | EVP & Chief Commercial Officer | Sell | $16K | 2024-02-02 |
| Raul R. Rodriguez | CEO & President | Sell | $36K | 2023-02-06 |
| Wolfgang Dummer | EVP & CMO | Sell | $9K | 2023-02-02 |
| David A. Santos | EVP & Chief Commercial Officer | Sell | $9K | 2023-02-02 |
| Raul R. Rodriguez | CEO & President | Buy | $690K | 2022-06-09 |
| Dean L. Schorno | CFO & VP | Buy | $206K | 2019-05-22 |